2. Signaling Pathways
  3. Others
  4. Isotope-Labeled Compounds

Isotope-Labeled Compounds

Isotope-labeled compounds are chemical substances in which some atoms in their molecules are replaced by isotope atoms. The range of stable isotope products can cover from gases to complex molecules. Isotope-labeled compounds could provide a site-specific investigation of structures, making molecules easily detectable by mass spectrometry and NMR, and maintaining the physico-chemical properties of the target molecule at the same time. MCE isotope-labeled compounds are all stable isotope-labeled compounds and are non-radioactive labeled substances. MCE isotope-labeled compounds are unique tools for identifying and understanding biological and chemical processes. Stable isotope-labeled products are now getting more and more popular among scientists. The scope of application is gradually penetrating into various scientific fields, such as life sciences, food and medicine, agriculture, environment, geology, etc. Stable isotope-labeled compounds have a wide range of applications in the Life Science areas, such as Metabolomics, Proteomics, Clinical studies, Deuterium drugs, etc.

Isotope-Labeled Compounds Related Products (9895):

Cat. No. Product Name Effect Purity Chemical Structure
  • HY-144348S
    N-[4-(2-Pyridinyl)benzoyl]glycine-13C2,15N
    N-[4-(2-Pyridinyl)benzoyl]glycine-13C2,15N is a 15N-labeled and 13C-labled labeled N-[4-(2-Pyridinyl)benzoyl]glycine.
    N-[4-(2-Pyridinyl)benzoyl]glycine-<sup>13</sup>C<sub>2</sub>,<sup>15</sup>N
  • HY-W741222S
    N-Desmethyl Olopatadine-d6
    N-Desmethyl Olopatadine-d6 is deuterium-labeled N-Desmethyl Olopatadine (HY-W741222).
    N-Desmethyl Olopatadine-d<sub>6</sub>
  • HY-150532S
    (Rac)-Vitamin B5,Calcium Salt Hydrate-13C3, 15N
    (Rac)-Vitamin B5,Calcium Salt Hydrate-13C3, 15N is the 13C and 15N labeled (Rac)-Vitamin B5,Calcium Salt Hydrate.
    (Rac)-Vitamin B5,Calcium Salt Hydrate-<sup>13</sup>C<sub>3</sub>, <sup>15</sup>N
  • HY-10208S2
    Pazopanib-d3
    Pazopanib-d3 (GW786034-d3) is deuterium labeled Pazopanib. Pazopanib (GW786034) is a novel multi-target inhibitor of VEGFR1, VEGFR2, VEGFR3, PDGFRβ, c-Kit, FGFR1, and c-Fms with IC50s of 10, 30, 47, 84, 74, 140 and 146 nM, respectively.
    Pazopanib-d<sub>3</sub>
  • HY-W653760
    Carbofuran-d3
    Carbofuran-d3 is the deuterium labeled Carbofuran.
    Carbofuran-d<sub>3</sub>
  • HY-W016321S
    N-Benzylaniline-d2
    N-Benzylaniline-d2 (N-Phenylbenzylamine-d2) is the deuterium labeled N-Benzylaniline (HY-W016321). N-Benzylaniline is an N-alkyl-ated derivative of aniline.
    N-Benzylaniline-d<sub>2</sub>
  • HY-Y1069S3
    (S)-Malic acid-13C4
    		98.0%
    (S)-Malic acid-13C4 is the 13C labeled S-Malic acid (HY-Y1069).
    (S)-Malic acid-<sup>13</sup>C<sub>4</sub>
  • HY-W143071S
    1-(Methylthio)-pentane-d3
    1-(Methylthio)-pentane-d3 is the deuterium labeled Amyl methyl sulfide (HY-W143071).
    1-(Methylthio)-pentane-d<sub>3</sub>
  • HY-121246S
    Fluorofenidone-d3
    Fluorofenidone-d3 (AKF-PD-d3) is deuterium labeled Fluorofenidone (AKF-PD) (HY-121246). Fluorofenidone is an orally active compound with anti-fibrotic, antioxidant, and anti-inflammatory pharmacological effects. Fluorofenidone downregulates the expression of ACSL4, upregulates GPX4 expression and inhibits the NF-κB signaling pathway to alleviate inflammation and fibrosis. Fluorofenidone ameliorates cholestasis and fibrosis by inhibiting hepatic Erk/-Egr-1 signaling and Tgfβ1/Smad pathway in mice. Fluorofenidone demonstrates protective effects against chronic lung injury in mice. Fluorofenidone can be used for the study of chronic obstructive pulmonary disease (COPD), pulmonary interstitial fibrosis (PIF) and non-small cell lung cancer (NSCLC).
    Fluorofenidone-d<sub>3</sub>
  • HY-A0118S1
    Naloxegol-13C,d2
    Naloxegol-13C,d2 (NKTR-118-13C,d2) is 13C labeled Naloxegol. Naloxegol (NKTR-118; AZ-13337019) is a μ-opioid-receptor antagonist. Naloxegol inhibits opioid binding in μ-opioid receptors in the gastrointestinal tract and effective for alleviating opioid-induced constipation.
    Naloxegol-<sup>13</sup>C<sub>,d<sub>2</sub>
  • HY-15651S
    Alvelestat-13C,d3
    Alvelestat-13C,d3 (AZD9668-13C,d3) is 13C-labeled Alvelestat (HY-15651).
    Alvelestat-<sup>13</sup>C,d<sub>3</sub>
  • HY-132453S
    Salbutamon-d9 hydrochloride
    Salbutamon-d9 hydrochloride is the deuterium labeled Salbutamon hydrochloride.
    Salbutamon-d9 hydrochloride
  • HY-A0070AS3
    Liothyronine-d3
    Liothyronine-d3 is deuterated labeled Liothyronine (HY-A0070A). Liothyronine is an active form of thyroid hormone. Liothyronine is a potent thyroid hormone receptors TRα and TRβ agonist with Kis of 2.33 nM for hTRα and hTRβ, respectively.
    Liothyronine-d<sub>3</sub>
  • HY-W769017
    Thiothiamine-13C3
    Thiothiamine-13C3 is 13C labeled Thiothiamine.
    Thiothiamine-<sup>13</sup>C<sub>3</sub>
  • HY-166891S
    Tiotropium EP Impurity G-d3(Iodide)
    Tiotropium EP Impurity G-d3(Iodide) is deuterium labeled Scopine Methiodide.
    Tiotropium EP Impurity G-d<sub>3</sub>(Iodide)
  • HY-W009815S
    6-Heptyltetrahydro-2H-pyran-2-one-d2
    6-Heptyltetrahydro-2H-pyran-2-one-d2 is deuterated labeled 6-Heptyltetrahydro-2H-pyran-2-one.
    6-Heptyltetrahydro-2H-pyran-2-one-d<sub>2</sub>
  • HY-135566S
    Clenpenterol-d5 hydrochloride
    Clenpenterol-d5 (hydrochloride) is deuterium labeled Clenpenterol (hydrochloride).
    Clenpenterol-d<sub>5</sub> hydrochloride
  • HY-W718614S
    2,3,3′,4,5,5′-Hexachloro biphenyl-13C12
    2,3,3′,4,5,5′-Hexachloro biphenyl-13C12 is 13C labeled 2,3,3',4,5,5'-Hexachloro-1,1'-biphenyl.
    2,3,3′,4,5,5′-Hexachloro biphenyl-<sup>13</sup>C<sub>12</sub>
  • HY-B0141S6
    Estradiol-d2-1
    Estradiol-d2-1 is the deuterium labeled Estradiol. Estradiol is a steroid sex hormone vital to the maintenance of fertility and secondary sexual characteristics in females. Estradiol upregulates IL-6 expression through the estrogen receptor β (ERβ) pathway.
    Estradiol-d<sub>2</sub>-1
  • HY-W101298S
    (Leu-13C6,15N)-Ile-OH TFA
    (Leu-13C6,15N)-Ile-OH (L-Leucyl-13C6,15N-L-isoleucine) TFA is the deuterium labeled Leu-Ile-OH. Leu-Ile-OH protects against neuronal death by inducing brain-derived neurotrophic factor (BDNF) and glial cell line-derived neurotrophic factor (GDNF) synthesis.
    (Leu-<sup>13</sup>C<sub>6</sub>,<sup>15</sup>N)-Ile-OH TFA